{"id":18869,"date":"2020-12-27T12:51:08","date_gmt":"2020-12-27T12:51:08","guid":{"rendered":"http:\/\/evaggelatos.com\/?p=18869"},"modified":"2020-12-27T20:00:16","modified_gmt":"2020-12-27T20:00:16","slug":"%cf%80%ce%b1%cf%81%ce%b5%ce%bd%ce%b5%cf%81%ce%b3%ce%b5%ce%b9%ce%b5%cf%83-%ce%b1%cf%80%ce%bf-%cf%84%ce%bf-%ce%b5%ce%bc%ce%b2%ce%bf%ce%bb%ce%b9%ce%bf-mrna-%cf%83%cf%84%ce%b7%ce%bd-%ce%b1%ce%b3%ce%b3","status":"publish","type":"post","link":"https:\/\/evaggelatos.com\/?p=18869","title":{"rendered":"\u03a0\u0391\u03a1\u0395\u039d\u0395\u03a1\u0393\u0395\u0399\u0395\u03a3 \u0391\u03a0\u039f \u03a4\u039f \u0395\u039c\u0392\u039f\u039b\u0399\u039f mRNA \u03a3\u03a4\u0397\u039d \u0391\u0393\u0393\u039b\u0399\u0391 \u03a3\u03a5\u039c\u03a6\u03a9\u039d\u0391 \u039c\u0395 \u03a4\u039f\u039d CDC \u0391\u0393\u0393\u039b\u0399\u0391\u03a3"},"content":{"rendered":"
\n
\n
\n
\u039c\u03ad\u03c7\u03c1\u03b9 \u03ce\u03c1\u03b1\u03c2 \u03bc\u03cc\u03bd\u03bf \u03b1\u03bd\u03b1\u03c6\u03c5\u03bb\u03b1\u03be\u03af\u03b1 \u03ad\u03c7\u03b5\u03b9 \u03c0\u03b1\u03c1\u03b1\u03c4\u03b7\u03c1\u03b7\u03b8\u03b5\u03af. \u039f \u0398\u03b5\u03cc\u03c2 \u03bd\u03b1 \u03b4\u03ce\u03c3\u03b5\u03b9 \u03bd\u03b1 \u03bc\u03b5\u03af\u03bd\u03bf\u03c5\u03bc\u03b5 \u03bc\u03ad\u03c7\u03c1\u03b9 \u03b5\u03ba\u03b5\u03af! <\/strong><\/span><\/div>\n
<\/div>\n
\u03a6\u03af\u03bb\u03b5\u03c2 , \u03a6\u03af\u03bb\u03bf\u03b9<\/div>\n
\u039a\u03b1\u03bb\u03b7\u03bc\u03ad\u03c1\u03b1<\/div>\n
<\/div>\n
\u039c\u03b5\u03c4\u03ac \u03b1\u03c0\u03cc \u03c4\u03bf \u0392\u03b1\u03bd\u03ac\u03ba\u03b9 \u03c0\u03bf\u03c5 \u03bc\u03b5\u03c4\u03ad\u03c6\u03b5\u03c1\u03b5 \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03c4\u03b7\u03c2 \u2018\u2019 \u0391\u03b3\u03af\u03b1\u03c2 Pfizer ” \u03c4\u03bf \u03c0\u03bf\u03b9\u03bd\u03b9\u03ba\u03cc \u03bc\u03b7\u03c4\u03c1\u03ce\u03bf \u03c4\u03b7\u03c2 \u03bf\u03c0\u03bf\u03af\u03b1\u03c2 \u03b8\u03b1 \u03c7\u03c1\u03b5\u03b9\u03b1\u03b6\u03cc\u03bc\u03b1\u03c3\u03c4\u03b1\u03bd \u03b5\u03ba\u03b1\u03c4\u03bf\u03bd\u03c4\u03ac\u03b4\u03b5\u03c2 \u03c3\u03b5\u03bb\u03af\u03b4\u03b5\u03c2 \u03b3\u03b9\u03b1 \u03bd\u03b1 \u03c4\u03c5\u03c0\u03c9\u03b8\u03b5\u03af \u03ba\u03b1\u03b9 \u03b8\u03b1 \u03c4\u03bf \u03b6\u03ae\u03bb\u03b5\u03c5\u03b5 \u03bf \u0391\u03bb \u039a\u03b1\u03c0\u03cc\u03bd\u03b5, \u03b1\u03c5\u03c4\u03cc \u03c4\u03bf \u03b2\u03b1\u03bd\u03ac\u03ba\u03b9 \u03c0\u03ad\u03c1\u03b1\u03c3\u03b5 \u03b1\u03c3\u03c5\u03bd\u03cc\u03b4\u03b5\u03c5\u03c4\u03bf \u03b1\u03c1\u03ba\u03b5\u03c4\u03ad\u03c2 \u03c7\u03ce\u03c1\u03b5\u03c2 \u03b1\u03bb\u03bb\u03ac \u03cc\u03c4\u03b1\u03bd \u03b5\u03b9\u03c3\u03ae\u03bb\u03b8\u03b5 \u03c3\u03c4\u03b7\u03bd \u03a7\u03ce\u03c1\u03b1 \u03c4\u03b7\u03c2 \u03a5\u03c0\u03ad\u03c1\u03ba\u03bf\u03bc\u03c8\u03b7\u03c2 \u039c\u03b1\u03c1\u03ad\u03b2\u03b1, \u03c3\u03c4\u03ae\u03b8\u03b7\u03ba\u03b5 \u03bf\u03bb\u03cc\u03ba\u03bb\u03b7\u03c1\u03bf show \u03c7\u03bf\u03bb\u03b9\u03b3\u03bf\u03c5\u03bd\u03c4\u03b9\u03b1\u03bd\u03ae\u03c2 \u03c5\u03c0\u03b5\u03c1\u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae\u03c2 \u03bc\u03b5 \u03b4\u03ae\u03b8\u03b5\u03bd\u00a0 ”\u03c4\u03c1\u03bf\u03bc\u03b5\u03c1\u03ac \u03bc\u03ad\u03c4\u03c1\u03b1 ” \u03c6\u03cd\u03bb\u03b1\u03be\u03b7\u03c2, \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u03bf\u03b9 \u03a5\u03c0\u03ae\u03ba\u03bf\u03bf\u03b9 (\u03c3.\u03b3.:\u03bc\u03ac\u03bb\u03bb\u03bf\u03bd \u03b4\u03bf\u03c5\u03bb\u03bf\u03c0\u03ac\u03c1\u03bf\u03b9\u03ba\u03bf\u03b9-\u03c0\u03c1\u03bf\u03b2\u03b1\u03c4\u03ac\u03ba\u03b9\u03b1 \u03bc\u03ad\u03c7\u03c1\u03b9 \u03bd\u03b1 \u03be\u03c5\u03c0\u03bd\u03ae\u03c3\u03bf\u03c5\u03bd \u03b1\u03bd \u03b4\u03b5\u03bd \u03ad\u03c7\u03bf\u03c5\u03bd \u03c9\u03c2 \u03c4\u03cc\u03c4\u03b5 \u03b1\u03bd\u03b1\u03bb\u03b7\u03c6\u03b8\u03b5\u03af \u03b5\u03b9\u03c2 \u039a\u03cd\u03c1\u03b9\u03bf\u03bd) \u03ba\u03b1\u03b9 \u03cc\u03c7\u03b9 \u03a0\u03bf\u03bb\u03af\u03c4\u03b5\u03c2 \u03c4\u03bf\u03c5 \u039c\u03c9\u03c5\u03c3\u03ae,<\/strong> \"\"\u03b3\u03bd\u03c9\u03c3\u03c4\u03cc\u03c4\u03b1\u03c4\u03bf\u03c2 \u03ba\u03b1\u03b9 \u03c9\u03c2 \u03c6\u03b5\u03c1\u03cc\u03bc\u03b5\u03bd\u03bf\u03c2 \u03a0\u03c1\u03c9\u03b8\u03c5\u03c0\u03bf\u03c5\u03c1\u03b3\u03cc\u03c2, \u03b8\u03b1 \u03ad\u03c7\u03bf\u03c5\u03bd \u03c4\u03b7\u03bd \u03b5\u03c5\u03ba\u03b1\u03b9\u03c1\u03af\u03b1 \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03ba\u03bf\u03bb\u03bf\u03c5\u03b8\u03ae\u03c3\u03bf\u03c5\u03bd \u03c4\u03bf \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03bf \u03bc\u03ad\u03c1\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03cc\u03bb\u03c5\u03c4\u03b7\u03c2 \u03b4\u03c5\u03c3\u03c4\u03bf\u03c0\u03b9\u03ba\u03ae\u03c2 \u03bc\u03b1\u03cd\u03c1\u03b7\u03c2 \u03ba\u03c9\u03bc\u03c9\u03b4\u03af\u03b1\u03c2 \u03bc\u03b5 \u03c4\u03bf\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03cc \u03c4\u03bf\u03c5 \u03c0\u03b1\u03c1\u03b1\u03c0\u03ac\u03bd\u03c9 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03c3\u03c5\u03bc\u03bc\u03b1\u03c7\u03af\u03b1\u03c2 \u03c4\u03c9\u03bd \u03c0\u03c1\u03bf\u03b8\u03cd\u03bc\u03c9\u03bd.<\/div>\n
\u0392\u03ad\u03b2\u03b1\u03b9\u03b1 \u03ba\u03b1\u03bd\u03b5\u03af\u03c2 \u03b4\u03b5\u03bd \u03b5\u03af\u03bd\u03b1\u03b9 \u03c3\u03b5 \u03b8\u03ad\u03c3\u03b7 \u03bd\u03b1 \u03b3\u03bd\u03c9\u03c1\u03af\u03b6\u03b5\u03b9 \u03b5\u03ac\u03bd \u03c4\u03bf ”\u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf” \u03b8\u03b1 \u03b5\u03af\u03bd\u03b1\u03b9\u00a0 \u039a\u03bf\u03c1\u03c0\u03ae \u03b7 \u0392\u03af\u03ba\u03bf\u03c2 \u03b7 \u039b\u03bf\u03c5\u03c4\u03c1\u03b1\u03ba\u03af\u03bf\u03c5. \u03a3\u03b5 \u03ba\u03ac\u03b8\u03b5 \u03c0\u03b5\u03c1\u03af\u03c0\u03c4\u03c9\u03c3\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c3\u03af\u03b3\u03bf\u03c5\u03c1\u03bf \u03cc\u03c4\u03b9 \u03b8\u03b1 \u03c0\u03b1\u03c1\u03b1\u03ba\u03bf\u03bb\u03bf\u03c5\u03b8\u03ae\u03c3\u03bf\u03c5\u03bc\u03b5 \u03c0\u03bf\u03bb\u03bb\u03ac \u03b5\u03c0\u03b5\u03b9\u03c3\u03cc\u03b4\u03b9\u03b1 \u03c4\u03b7\u03c2 \u03c6\u03b1\u03c1\u03c3\u03bf\u03ba\u03c9\u03bc\u03bc\u03c9\u03b4\u03af\u03b1\u03c2 \u039c\u03b1\u03cd\u03c1\u03b7\u03c2 \u03ba\u03b1\u03b9 \u0394\u03c5\u03c3\u03c4\u03bf\u03c0\u03b9\u03ba\u03ae\u03c2 \u03c0\u03ac\u03bd\u03c4\u03b1 .<\/div>\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\u039f \u03c5\u03c0\u03bf\u03b3\u03c1\u03ac\u03c6\u03c9\u03bd \u03c3\u03c5\u03bd\u03b5\u03c7\u03af\u03b6\u03bf\u03bd\u03c4\u03b1\u03c2 \u03c4\u03b7\u03bd \u03c0\u03c1\u03bf\u03c3\u03c0\u03ac\u03b8\u03b5\u03b9\u03b1 \u03c0\u03c1\u03b1\u03b3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae\u03c2 \u03b5\u03bd\u03b7\u03bc\u03ad\u03c1\u03c9\u03c3\u03b7\u03c2, \u03c3\u03b1\u03c2 \u03ba\u03bf\u03b9\u03bd\u03bf\u03c0\u03bf\u03b9\u03b5\u03af \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u03bb\u03bf\u03b9\u03c0\u03cc\u03bd\u00a0 \u03c4\u03b1 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03ad\u03c3\u03bc\u03b1\u03c4\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03b9\u03c2 \u03c0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03bf\u03c5\u03bd \u03c0\u03b1\u03c1\u03b1\u03c4\u03b7\u03c1\u03b7\u03b8\u03b5\u03af \u03c3\u03c4\u03b7\u03bd \u0391\u03b3\u03b3\u03bb\u03af\u03b1 \u03b1\u03c0\u03cc \u03c4\u03bf \u03c3\u03c5\u03b3\u03ba\u03b5\u03ba\u03c1\u03b9\u03bc\u03ad\u03bd\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf\u00a0 \u03bc\u03ad\u03c7\u03c1\u03b9 \u03ba\u03b1\u03b9 \u03c4\u03b9\u03c2 18\/12\/2020 \u03cc\u03c0\u03c9\u03c2 \u03c4\u03b1 \u03ba\u03b1\u03c4\u03b1\u03b3\u03c1\u03ac\u03c6\u03b5\u03b9 \u03bf \u0391\u03b3\u03b3\u03bb\u03b9\u03ba\u03cc\u03c2\u00a0 CDC, \u03b1\u03bd\u03c4\u03af\u03c3\u03c4\u03bf\u03b9\u03c7\u03bf\u03c2 \u03c4\u03bf\u03c5 \u03b4\u03b9\u03ba\u03bf\u03cd \u03bc\u03b1\u03c2 \u0395\u039f\u0394\u03a5. \u03a6\u03b1\u03bd\u03c4\u03b1\u03c3\u03b8\u03b5\u03af\u03c4\u03b5 \u03c4\u03b9 \u03ad\u03c7\u03b5\u03b9 \u03bd\u03b1 \u03b3\u03af\u03bd\u03b5\u03b9\u00a0 \u03b5\u03ac\u03bd \u03c4\u03c5\u03c7\u03cc\u03bd \u03c0\u03b1\u03c1\u03b1\u03c4\u03b7\u03c1\u03b7\u03b8\u03bf\u03cd\u03bd \u03ac\u03bb\u03bb\u03b5\u03c2 \u03c0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2 \u03bc\u03b5\u03c4\u03ac \u03b1\u03c0\u03cc \u03bc\u03ae\u03bd\u03b5\u03c2 \u03b7 \u03ba\u03b1\u03b9 \u03c7\u03c1\u03cc\u03bd\u03b9\u03b1 .<\/div>\n
<\/div>\n
\u0397 \u0391\u03bb\u03ae\u03b8\u03b5\u03b9\u03b1 \u03b4\u03b5\u03bd \u03ad\u03c7\u03b5\u03b9 \u03c7\u03bf\u03c1\u03b7\u03b3\u03bf\u03cd\u03c2.<\/div>\n
<\/div>\n
\u039c\u03b5 \u0395\u03ba\u03c4\u03af\u03bc\u03b7\u03c3\u03b7<\/div>\n
\u03a4\u03ac\u03c3\u03bf\u03c2 \u03a3\u03b1\u03bc\u03c0\u03ac\u03bd\u03b7\u03c2 , \u039f\u03b9\u03ba\u03bf\u03bd\u03bf\u03bc\u03bf\u03bb\u03cc\u03b3\u03bf\u03c2 (\u0391\u03c6\u03bf\u03cd \u03b4\u03b5\u03bd \u03bc\u03b9\u03bb\u03bf\u03cd\u03bd \u03bf\u03b9 \u03b3\u03b9\u03b1\u03c4\u03c1\u03bf\u03af \u03b1\u03bb\u03bb\u03ac \u03c5\u03c0\u03bf\u03c4\u03ac\u03c3\u03c3\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7\u03bd \u03ba\u03c5\u03b2\u03ad\u03c1\u03bd\u03b7\u03c3\u03b7 \u03ba\u03b1\u03b9 \u03c4\u03b1 \u03b1\u03c5\u03bb\u03cc\u03b4\u03bf\u03c5\u03bb\u03b1 \u039c\u039c\u0395).<\/div>\n<\/div>\n
\n

 <\/p>\n

Anaphylaxis Following m-RNA COVID-19
\nVaccine Receipt<\/p>\n

Thomas Clark, MD, MPH
\nDecember 19, 2020<\/p>\n

December 8, 2020<\/strong> \u2013 UK initiated vaccination with Pfizer-BioNTech
\nCOVID-19 vaccine
\nDecember 9<\/strong> \u2013 UK authorities confirmed 2 cases of anaphylaxis after<\/strong><\/span>
\nvaccination<\/strong><\/span>
\nPrescribing information for both Pfizer-BioNTech and Moderna COVID-19
\nvaccines contains information on anaphylaxis
\n\u2013 Severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine is a
\ncontraindication to vaccination
\n\u2013 Appropriate medical treatment used to manage immediate allergic reactions must
\nbe immediately available in the event an acute anaphylactic reaction occurs
\nfollowing administration of the vaccine Anaphylaxis<\/p>\n

CDC Guidance on Anaphylaxis Following COVID-19
\nVaccination<\/p>\n

ACIP considered anaphylaxis risk during deliberations on Pfizer-BioNTech
\nCOVID-19 vaccine during December 11-12 meetings<\/p>\n

December 12<\/strong> \u2013 CDC published clinical considerations for use of Pfizer-
\nBioNTech COVID-19 vaccine<\/p>\n

\u2013 Included guidance on contraindications and precautions<\/p>\n

(https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/clinical-
\nconsiderations.html#contraindications-precautions)[1]<\/p>\n

Anaphylaxis in US Following COVID-19 Vaccination<\/strong><\/p>\n

December 18*, 2020<\/strong> \u2013 CDC has identified 6 case reports of anaphylaxis<\/strong><\/span>
\nfollowing Pfizer-BioNTech vaccine meeting Brighton Collaboration criteria for<\/strong><\/span>
\nanaphylaxis<\/strong><\/span>
\n\u2013 Cases were Brighton Collaboration levels 1 or 2
\n\u2013 Additional case reports have been reviewed and determined not anaphylaxis
\nCases occurred within recommended observation window and were
\npromptly treated
\nOne case had a history of anaphylaxis following rabies vaccination
\nAll suspect cases were notified through VAERS or CDC notification processes
\nThese case reports are undergoing\/will undergo clinical case review by CISA
\nDecember 19**<\/strong> \u2013 272,001 doses of vaccine have been administered<\/p>\n

CDC Actions Following Reports<\/strong><\/p>\n<\/div>\n

Close coordination with FDA
\nDiscussions with CISA investigators, NIH, Medicine and Healthcare
\nproducts Regulatory Agency (UK), Allergy\/Immunology experts, and
\nother partners
\nPublished Interim Considerations: Preparing for the Potential
\nManagement of Anaphylaxis at COVID-19 Vaccination<\/p>\n

Sites (https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-
\nproduct\/pfizer\/anaphylaxis-management.html)<\/p>\n

V-safe Active Surveillance for COVID-19 Vaccines<\/p>\n

Dec 14 Dec 15 Dec 16 Dec 17 Dec 18*<\/p>\n

Registrants with recorded 1st dose 679 6,090 27,823 67,963 112,807<\/p>\n

Health Impact Events** 3 50 373 1,476 3,150<\/p>\n

Pregnancies at time of vaccination 5 29 103 286 514<\/p>\n

*Dec 18, 5:30 pm EST<\/strong>
\n**unable to perform normal daily activities, unable to work, required care from doctor or health care professional<\/strong><\/p>\n

Post-authorization pharmacovigilance systems have detected and
\nconfirmed 6 anaphylaxis cases following vaccination
\n\u2013 Notifications received have been timely
\n\u2013 Notifications ruled out suggests systems are sensitive
\nReinforce measures to recognize, respond, and report anaphylaxis
\nPersons with anaphylaxis following COVID-19 vaccination should not
\nreceive additional doses of COVID-19 vaccine
\nConsultation with allergy\/immunology experts to provide guidance on
\nevaluation of persons following anaphylaxis to COVID-19 vaccine
\nCDC Assessment and Further Actions<\/p>\n

For more information, contact CDC
\n1-800-CDC-INFO (232-4636)
\nTTY: 1-888-232-6348 www.cdc.gov<\/p>\n

The findings and conclusions in this report are those of the authors and do not necessarily represent the
\nofficial position of the Centers for Disease Control and Prevention.<\/p>\n

Thank you<\/p>\n

[1]Look at https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html<\/p>\n<\/div>\n<\/div>\n

 <\/p>\n

\n
\n
\n
\n
\n
\n
\n

\u0397 \u03a3\u03c5\u03bc\u03b2\u03bf\u03c5\u03bb\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae \u0395\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae \u03a0\u03c1\u03b1\u03ba\u03c4\u03b9\u03ba\u03ce\u03bd \u0391\u03bd\u03bf\u03c3\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7\u03c2 (ACIP) \u03b5\u03be\u03ad\u03b4\u03c9\u03c3\u03b5 \u03b5\u03bd\u03b4\u03b9\u03ac\u03bc\u03b5\u03c3\u03b5\u03c2 \u03c3\u03c5\u03c3\u03c4\u03ac\u03c3\u03b5\u03b9\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03b7 \u03c7\u03c1\u03ae\u03c3\u03b7 \u00a0\u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd Pfizer-BioNTech<\/a> \u03ba\u03b1\u03b9 Moderna<\/a> COVID-19 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7 \u03c4\u03b7\u03c2 \u03bd\u03cc\u03c3\u03bf\u03c5 \u03c4\u03bf\u03c5 \u03ba\u03bf\u03c1\u03bf\u03bd\u03b1\u03ca\u03bf\u03cd 2019 (COVID-19) \u03c3\u03c4\u03b9\u03c2 \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03b5\u03c2 \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03af\u03b5\u03c2. \u039a\u03b1\u03b9 \u03c4\u03b1 \u03b4\u03cd\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03b1 \u03bc\u03b5 \u03bb\u03b9\u03c0\u03af\u03b4\u03b9\u03b1 \u03bd\u03b1\u03bd\u03bf\u03c3\u03c9\u03bc\u03b1\u03c4\u03b9\u03b4\u03af\u03c9\u03bd, \u03c4\u03c1\u03bf\u03c0\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b1 \u03bc\u03b5 \u03bd\u03bf\u03c5\u03ba\u03bb\u03b5\u03bf\u03c3\u03b9\u03b4\u03b9\u03ba\u03ac mRNA \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03c0\u03bf\u03c5 \u03ba\u03c9\u03b4\u03b9\u03ba\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd \u03c4\u03b7\u03bd \u03c0\u03c1\u03bf\u03c9\u03b8\u03b7\u03c4\u03b9\u03ba\u03ae \u03b3\u03bb\u03c5\u03ba\u03bf\u03c0\u03c1\u03c9\u03c4\u03b5\u0390\u03bd\u03b7 \u03c4\u03bf\u03c5 SARS-CoV-2, \u03c4\u03bf\u03bd \u03b9\u03cc \u03c0\u03bf\u03c5 \u03c0\u03c1\u03bf\u03ba\u03b1\u03bb\u03b5\u03af \u03c4\u03bf COVID-19.<\/p>\n

\u0391\u03c5\u03c4\u03ad\u03c2 \u03bf\u03b9 \u03b5\u03bd\u03b4\u03b9\u03ac\u03bc\u03b5\u03c3\u03b5\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03b5\u03ba\u03c4\u03b9\u03bc\u03ae\u03c3\u03b5\u03b9\u03c2 CDC \u03b5\u03bd\u03b7\u03bc\u03b5\u03c1\u03ce\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03bc\u03b5 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1 \u03c0\u03bf\u03c5 \u03c5\u03c0\u03bf\u03b2\u03ac\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7\u03bd \u03a5\u03c0\u03b7\u03c1\u03b5\u03c3\u03af\u03b1 \u03a4\u03c1\u03bf\u03c6\u03af\u03bc\u03c9\u03bd \u03ba\u03b1\u03b9 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd \u03b3\u03b9\u03b1 \u0386\u03b4\u03b5\u03b9\u03b1 \u0388\u03ba\u03c4\u03b1\u03ba\u03c4\u03b7\u03c2 \u03a7\u03c1\u03ae\u03c3\u03b7\u03c2 (EUA) \u03b3\u03b9\u03b1 \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1, \u03ac\u03bb\u03bb\u03b5\u03c2 \u03c0\u03b7\u03b3\u03ad\u03c2 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03c9\u03bd, \u03b3\u03b5\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bf\u03b4\u03b7\u03b3\u03af\u03b5\u03c2 \u03b2\u03ad\u03bb\u03c4\u03b9\u03c3\u03c4\u03b7\u03c2 \u03c0\u03c1\u03b1\u03ba\u03c4\u03b9\u03ba\u03ae\u03c2 \u03b3\u03b9\u03b1 \u03b1\u03bd\u03bf\u03c3\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7<\/a> \u03ba\u03b1\u03b9 \u03b3\u03bd\u03c9\u03bc\u03bf\u03b4\u03cc\u03c4\u03b7\u03c3\u03b7 \u03b5\u03bc\u03c0\u03b5\u03b9\u03c1\u03bf\u03b3\u03bd\u03c9\u03bc\u03cc\u03bd\u03c9\u03bd. \u0391\u03c5\u03c4\u03ad\u03c2 \u03bf\u03b9 \u03b5\u03ba\u03c4\u03b9\u03bc\u03ae\u03c3\u03b5\u03b9\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 mRNA \u03b9\u03c3\u03c7\u03cd\u03bf\u03c5\u03bd \u03bc\u03cc\u03bd\u03bf \u03b3\u03b9\u03b1 \u03c4\u03b1 \u03b5\u03c0\u03af \u03c4\u03bf\u03c5 \u03c0\u03b1\u03c1\u03cc\u03bd\u03c4\u03bf\u03c2 \u03b5\u03b3\u03ba\u03b5\u03ba\u03c1\u03b9\u03bc\u03ad\u03bd\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd \u03c3\u03c4\u03b9\u03c2 \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03b5\u03c2 \u03a0\u03bf\u03bb\u03b9\u03c4\u03b5\u03af\u03b5\u03c2 (\u03c0.\u03c7. \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 Pfizer-BioNTech \u03ba\u03b1\u03b9 Moderna COVID-19). <\/span>\u039f\u03b9 \u03b5\u03ba\u03c4\u03b9\u03bc\u03ae\u03c3\u03b5\u03b9\u03c2 \u03b8\u03b1 \u03b5\u03bd\u03b7\u03bc\u03b5\u03c1\u03c9\u03b8\u03bf\u03cd\u03bd \u03ba\u03b1\u03b8\u03ce\u03c2 \u03b4\u03b9\u03b1\u03c4\u03af\u03b8\u03b5\u03bd\u03c4\u03b1\u03b9 \u03c0\u03c1\u03cc\u03c3\u03b8\u03b5\u03c4\u03b5\u03c2 \u03c0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 \u03ae \u03b5\u03ac\u03bd \u03b5\u03b3\u03ba\u03c1\u03b9\u03b8\u03bf\u03cd\u03bd \u03c0\u03c1\u03cc\u03c3\u03b8\u03b5\u03c4\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd.<\/p>\n

\u0395\u03ba\u03c4\u03cc\u03c2 \u03b1\u03c0\u03cc \u03c4\u03b9\u03c2 \u03b1\u03ba\u03cc\u03bb\u03bf\u03c5\u03b8\u03b5\u03c2 \u03b5\u03ba\u03c4\u03b9\u03bc\u03ae\u03c3\u03b5\u03b9\u03c2, \u03bf\u03b9 \u03cc\u03c1\u03bf\u03b9 \u03c7\u03c1\u03ae\u03c3\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7\u03c2, \u03c7\u03b5\u03b9\u03c1\u03b9\u03c3\u03bc\u03bf\u03cd \u03ba\u03b1\u03b9 \u03b4\u03b9\u03b1\u03c7\u03b5\u03af\u03c1\u03b9\u03c3\u03b7\u03c2 \u03c4\u03c9\u03bd EUA \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03ac\u03c6\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b9\u03c2 \u03c0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 \u03c3\u03c5\u03bd\u03c4\u03b1\u03b3\u03bf\u03b3\u03c1\u03ac\u03c6\u03b7\u03c3\u03b7\u03c2 \u03c0\u03c1\u03ad\u03c0\u03b5\u03b9 \u03bd\u03b1 \u03b1\u03bd\u03b1\u03c6\u03ad\u03c1\u03bf\u03bd\u03c4\u03b1\u03b9 \u03ba\u03b1\u03c4\u03ac \u03c4\u03b7 \u03c7\u03c1\u03ae\u03c3\u03b7 \u03c4\u03bf\u03c5 Pfizer-BioNTech\u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03b5\u03b9\u03ba\u03bf\u03bd\u03af\u03b4\u03b9\u03bf<\/span><\/a>\u03ba\u03b1\u03b9 Moderna\u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03b5\u03b9\u03ba\u03bf\u03bd\u03af\u03b4\u03b9\u03bf<\/span><\/a> \u0395\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd covid19.<\/p>\n

\u0395\u03be\u03bf\u03c5\u03c3\u03b9\u03bf\u03b4\u03bf\u03c4\u03b7\u03bc\u03ad\u03bd\u03b5\u03c2 \u03b7\u03bb\u03b9\u03ba\u03b9\u03b1\u03ba\u03ad\u03c2 \u03bf\u03bc\u03ac\u03b4\u03b5\u03c2<\/span><\/h2>\n

\u03a3\u03cd\u03bc\u03c6\u03c9\u03bd\u03b1 \u03bc\u03b5 \u03c4\u03b9\u03c2 EUAs, \u03bf\u03b9 \u03b1\u03ba\u03cc\u03bb\u03bf\u03c5\u03b8\u03b5\u03c2 \u03b7\u03bb\u03b9\u03ba\u03b9\u03b1\u03ba\u03ad\u03c2 \u03bf\u03bc\u03ac\u03b4\u03b5\u03c2 \u03b5\u03be\u03bf\u03c5\u03c3\u03b9\u03bf\u03b4\u03bf\u03c4\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03bd\u03b1 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03c4\u03bf\u03cd\u03bd:<\/p>\n